|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245.33 USD | +0.33% |
|
-4.62% | +25.73% |
| 04-10 | Boston Beer Moves for Post-Trial Motions in Ardagh Contract Dispute | MT |
| 04-10 | Boston Beer Co Inc - Jury verdict orders Boston Beer to pay $175.5 million in damages to Ardagh - SEC filing | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.58 | 5.61 | 5.34 | 7.08 | 7.77 | |||||
Return on Total Capital | 3.44 | 7.25 | 6.77 | 9.12 | 10.31 | |||||
Return On Equity % | 1.5 | 6.56 | 7.1 | 5.99 | 12.31 | |||||
Return on Common Equity | 1.49 | 6.54 | 7.09 | 5.97 | 12.27 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.77 | 41.24 | 42.44 | 44.4 | 48.48 | |||||
SG&A Margin | 35.99 | 35.21 | 36.37 | 36.86 | 40.75 | |||||
EBITDA Margin % | 6.28 | 9.92 | 10.45 | 12.21 | 12.33 | |||||
EBITA Margin % | 2.79 | 6.04 | 6.08 | 7.57 | 7.81 | |||||
EBIT Margin % | 2.78 | 6.03 | 6.06 | 7.54 | 7.73 | |||||
Income From Continuing Operations Margin % | 0.71 | 3.22 | 3.8 | 2.97 | 5.52 | |||||
Net Income Margin % | 0.71 | 3.22 | 3.8 | 2.97 | 5.52 | |||||
Net Avail. For Common Margin % | 0.7 | 3.21 | 3.79 | 2.96 | 5.5 | |||||
Normalized Net Income Margin | 1.7 | 3.79 | 4.09 | 5.07 | 5.1 | |||||
Levered Free Cash Flow Margin | -4.57 | 5.16 | 9.04 | 7.53 | 9.7 | |||||
Unlevered Free Cash Flow Margin | -4.57 | 5.16 | 9.04 | 7.53 | 9.7 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.49 | 1.49 | 1.41 | 1.5 | 1.61 | |||||
Fixed Assets Turnover | 2.94 | 2.93 | 2.89 | 3.04 | 3.14 | |||||
Receivables Turnover (Average Receivables) | 30.85 | 37.43 | 32.48 | 31.35 | 33.16 | |||||
Inventory Turnover (Average Inventory) | 9 | 8.26 | 8.75 | 9.61 | 9.66 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.35 | 2.07 | 2.25 | 1.8 | 1.65 | |||||
Quick Ratio | 0.53 | 1.21 | 1.64 | 1.21 | 1.21 | |||||
Operating Cash Flow to Current Liabilities | 0.22 | 0.98 | 1.19 | 1.07 | 1.07 | |||||
Days Sales Outstanding (Average Receivables) | 11.8 | 9.91 | 11.21 | 11.61 | 10.98 | |||||
Days Outstanding Inventory (Average Inventory) | 40.45 | 44.94 | 41.59 | 37.88 | 37.7 | |||||
Average Days Payable Outstanding | 29.56 | 25.71 | 27.78 | 28.34 | 33.58 | |||||
Cash Conversion Cycle (Average Days) | 22.69 | 29.14 | 25.02 | 21.14 | 15.09 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.56 | 5.2 | 4.45 | 4.23 | 4.61 | |||||
Total Debt / Total Capital | 6.16 | 4.95 | 4.26 | 4.06 | 4.4 | |||||
LT Debt/Equity | 5.62 | 4.29 | 3.49 | 3.4 | 2.97 | |||||
Long-Term Debt / Total Capital | 5.28 | 4.07 | 3.34 | 3.26 | 2.84 | |||||
Total Liabilities / Total Assets | 29.09 | 24.79 | 24.62 | 26.71 | 29.1 | |||||
EBIT / Interest Expense | 519.76 | - | - | - | - | |||||
EBITDA / Interest Expense | 1.28K | - | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | -65.76 | - | - | - | - | |||||
Total Debt / EBITDA | 0.46 | 0.25 | 0.22 | 0.15 | 0.15 | |||||
Net Debt / EBITDA | 0.27 | -0.57 | -1.14 | -0.68 | -0.72 | |||||
Total Debt / (EBITDA - Capex) | -8.92 | 0.44 | 0.31 | 0.22 | 0.19 | |||||
Net Debt / (EBITDA - Capex) | -5.21 | -0.98 | -1.62 | -0.96 | -0.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.5 | 1.59 | -3.91 | 0.21 | -2.38 | |||||
Gross Profit, 1 Yr. Growth % | -2.05 | 8.05 | -1.12 | 4.85 | 6.58 | |||||
EBITDA, 1 Yr. Growth % | -58.87 | 60.45 | 1.23 | 17.06 | -1.43 | |||||
EBITA, 1 Yr. Growth % | -76.93 | 119.94 | -3.35 | 24.85 | 0.75 | |||||
EBIT, 1 Yr. Growth % | -77.01 | 120.47 | -3.36 | 24.6 | 0.03 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -92.42 | 362.19 | 13.36 | -21.71 | 81.71 | |||||
Net Income, 1 Yr. Growth % | -92.42 | 362.19 | 13.36 | -21.71 | 81.71 | |||||
Normalized Net Income, 1 Yr. Growth % | -77.45 | 125.9 | 3.72 | 24.36 | -1.84 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -92.47 | 364.51 | 14.2 | -18.46 | 95.4 | |||||
Accounts Receivable, 1 Yr. Growth % | -29.78 | 3 | 18.22 | -8.32 | -7.05 | |||||
Inventory, 1 Yr. Growth % | 13.91 | -0.45 | -22.01 | 1.2 | -21.02 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.29 | -0.82 | -4.72 | -5.01 | -5.55 | |||||
Total Assets, 1 Yr. Growth % | 0.58 | 2.45 | 0.65 | -12.59 | -4.51 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.6 | 14.66 | 2.96 | -13.09 | -8.67 | |||||
Common Equity, 1 Yr. Growth % | 2.76 | 8.66 | 0.88 | -15 | -7.63 | |||||
Cash From Operations, 1 Yr. Growth % | -77.78 | 255.16 | 32.61 | -6.13 | 8.54 | |||||
Capital Expenditures, 1 Yr. Growth % | 5.66 | -38.76 | -29.25 | 19.02 | -28.47 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -191.15 | -214.8 | 54.08 | -16.55 | 25.74 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -190.98 | -214.88 | 54.08 | -16.55 | 25.74 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 28.31 | 9.72 | -1.2 | -1.87 | -1.09 | |||||
Gross Profit, 2 Yr. CAGR % | 13.97 | 2.88 | 3.36 | 1.82 | 5.72 | |||||
EBITDA, 2 Yr. CAGR % | -20.02 | -18.77 | 27.45 | 8.86 | 7.42 | |||||
EBITA, 2 Yr. CAGR % | -37.27 | -28.77 | 45.8 | 9.96 | 12.26 | |||||
EBIT, 2 Yr. CAGR % | -37.38 | -28.8 | 45.97 | 9.74 | 11.64 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -63.63 | -40.81 | 128.9 | -5.79 | 19.27 | |||||
Net Income, 2 Yr. CAGR % | -63.63 | -40.81 | 128.9 | -5.79 | 19.27 | |||||
Normalized Net Income, 2 Yr. CAGR % | -37.87 | -28.62 | 53.07 | 13.57 | 10.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -64.26 | -40.85 | 130.32 | -3.5 | 26.22 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.57 | -14.96 | 10.35 | 4.11 | -7.69 | |||||
Inventory, 2 Yr. CAGR % | 18.59 | 6.49 | -11.89 | -11.16 | -10.6 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.84 | 2.19 | -2.79 | -4.87 | -5.28 | |||||
Total Assets, 2 Yr. CAGR % | 14.7 | 1.51 | 1.55 | -6.2 | -8.64 | |||||
Tangible Book Value, 2 Yr. CAGR % | 21.6 | 8.99 | 8.66 | -5.4 | -10.9 | |||||
Common Equity, 2 Yr. CAGR % | 15.62 | 5.67 | 4.7 | -7.4 | -11.39 | |||||
Cash From Operations, 2 Yr. CAGR % | -43.8 | -11.17 | 117.02 | 11.57 | 0.94 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.96 | -19.56 | -34.18 | -8.24 | -7.73 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 23.01 | 2.29 | 47.3 | 13.39 | 2.44 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 22.96 | 2.23 | 47.36 | 13.39 | 2.44 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 27.38 | 18.7 | 4.97 | -0.73 | -2.04 | |||||
Gross Profit, 3 Yr. CAGR % | 15.91 | 11.96 | 1.53 | 3.86 | 3.39 | |||||
EBITDA, 3 Yr. CAGR % | -8.46 | 0.87 | -12.58 | 23.89 | 5.32 | |||||
EBITA, 3 Yr. CAGR % | -21.01 | -4.7 | -21.14 | 38.45 | 6.8 | |||||
EBIT, 3 Yr. CAGR % | -21.13 | -4.74 | -21.17 | 38.47 | 6.4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -46.05 | -15.13 | -26.49 | 60.08 | 17.27 | |||||
Net Income, 3 Yr. CAGR % | -46.05 | -15.13 | -26.49 | 60.08 | 17.27 | |||||
Normalized Net Income, 3 Yr. CAGR % | -21.72 | -4.46 | -19.16 | 42.83 | 8.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -46.92 | -15.97 | -26.34 | 62.93 | 22.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.32 | 1.37 | -5.09 | 3.74 | 0.25 | |||||
Inventory, 3 Yr. CAGR % | 28.52 | 11.87 | -4.01 | -7.73 | -14.58 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 22.56 | 6.16 | -0.17 | -3.54 | -5.09 | |||||
Total Assets, 3 Yr. CAGR % | 29.41 | 10.46 | 1.22 | -3.4 | -5.64 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.06 | 19.24 | 6.94 | 0.86 | -6.5 | |||||
Common Equity, 3 Yr. CAGR % | 28.79 | 13.25 | 4.05 | -2.33 | -7.48 | |||||
Cash From Operations, 3 Yr. CAGR % | -29.9 | 3.9 | 1.52 | 64.13 | 10.55 | |||||
Capital Expenditures, 3 Yr. CAGR % | 38.68 | -0.96 | -22.93 | -19.81 | -15.55 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.59 | 20.21 | 20.77 | 21.88 | 17.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.57 | 20.21 | 20.72 | 21.91 | 17.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.82 | 19.36 | 15.07 | 10 | 2.5 | |||||
Gross Profit, 5 Yr. CAGR % | 11.66 | 13.89 | 10.72 | 7.79 | 3.18 | |||||
EBITDA, 5 Yr. CAGR % | -7.12 | 4.13 | 4.5 | 3.99 | -5.07 | |||||
EBITA, 5 Yr. CAGR % | -16.01 | 1.35 | 0.93 | 0.87 | -9.21 | |||||
EBIT, 5 Yr. CAGR % | -16.09 | 1.31 | 0.89 | 0.81 | -9.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -30.12 | -7.45 | -3.82 | -11.51 | -10.79 | |||||
Net Income, 5 Yr. CAGR % | -30.12 | -7.45 | -3.82 | -11.51 | -10.79 | |||||
Normalized Net Income, 5 Yr. CAGR % | -16.34 | 1.33 | 2.36 | 2.38 | -8.4 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -29.65 | -7.64 | -4.52 | -11.19 | -8.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.44 | 10.92 | 14.48 | 2.46 | -6.14 | |||||
Inventory, 5 Yr. CAGR % | 23.22 | 23.99 | 10.51 | 2.01 | -6.7 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.93 | 13.12 | 11.71 | 1.6 | -2.25 | |||||
Total Assets, 5 Yr. CAGR % | 17.62 | 20.06 | 17.45 | 3.47 | -2.84 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.72 | 16.06 | 14.79 | 8.7 | -0.59 | |||||
Common Equity, 5 Yr. CAGR % | 17.1 | 20.33 | 18.55 | 4.49 | -2.43 | |||||
Cash From Operations, 5 Yr. CAGR % | -18.25 | 8.02 | 10.16 | 6.91 | 1.29 | |||||
Capital Expenditures, 5 Yr. CAGR % | 24.27 | 22.39 | 2.93 | -3.94 | -17.18 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -2.86 | 1.78 | 18.54 | 19.53 | 13.07 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -2.88 | 1.78 | 18.54 | 19.53 | 13.04 |
- Stock Market
- Equities
- SAM Stock
- Financials The Boston Beer Company, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















